Heart failure with reduced and preserved ejection fraction, pathophysiology and treatment
Sequencing of treatments for heart failure with reduced ejection fraction (HFrEF)
Therapy for Heart Failure w/ Reduced Ejection Fraction - When & How to Introduce SGLT2 Inhibitors
Drugs for Heart Failure with Preserved Ejection Fraction
The 2022 Guideline for the Management of Heart Failure: An Expert-Guided Tour
Dr. Stephanie Poon: Modernizing the treatment of heart failure with reduced ejection fraction
Heart Failure Guidelines Webinar
The art and science of medication optimization for heart failure with reduced ejection fraction
A closer look at the new heart failure guidelines
Best Practices for Starting SGLT2 Inhibitors in HFpEF Treatment
What’s New in 2023 in the Management of Heart Failure?
Goal Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction
Optimizing Guideline-Directed Medical Therapy in HFrEF: Beta-Blockers
Heart Failure Care in 2018: still a work in progress
ESC Guidelines: Managing HFmrEF (English Version)
What do current guidelines recommend for the treatment of HFpEF?
Guideline Directed Medical Therapy (GDMT) for Heart Failure
Heart failure- NICE guideline
HFpEF New Guidelines Are Pertinent for Primary Care
Heart Failure management | Heart failure with reduced ejection fraction